| 1 |
33609728 | Evaluation of Virola oleifera activity in musculoskeletal pathologies: Inhibition of human multiple myeloma cells proliferation and combination therapy with dexamethasone or bortezomib. | 2021 May 23 |
1 |
| 2 |
29057477 | The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs. | 2018 May |
1 |
| 3 |
29482577 | Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma. | 2018 Feb 27 |
1 |
| 4 |
30094097 | Trametinib suppresses chemotherapy-induced cold and mechanical allodynia via inhibition of extracellular-regulated protein kinase 1/2 activation. | 2018 |
2 |
| 5 |
28161489 | Antiproliferative effects of Bortezomib in endothelial cells transformed by viral G protein-coupled receptor associated to Kaposi's sarcoma. | 2017 Apr |
5 |
| 6 |
24618474 | Characterization of p38 MAPK isoforms for drug resistance study using systems biology approach. | 2014 Jul 1 |
1 |
| 7 |
23975859 | Bortezomib induces apoptosis and autophagy in osteosarcoma cells through mitogen-activated protein kinase pathway in vitro. | 2013 Oct |
1 |
| 8 |
22532603 | Proteasome inhibition blocks NF-κB and ERK1/2 pathways, restores antigen expression, and sensitizes resistant human melanoma to TCR-engineered CTLs. | 2012 Jun |
1 |
| 9 |
22848091 | PKCδ regulates death receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis in human lung cancer cells. | 2012 Oct |
1 |
| 10 |
21755010 | Small compound 6-O-angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myeloma. | 2011 |
1 |
| 11 |
18776064 | Bortezomib-induced survival signals and genes in human proximal tubular cells. | 2008 Dec |
1 |
| 12 |
17762396 | Antitumor effects and drug interactions of the proteasome inhibitor bortezomib (PS341) in gastric cancer cells. | 2007 Jul |
1 |
| 13 |
16546981 | Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells. | 2006 Mar |
1 |
| 14 |
15609327 | Bortezomib is an efficient agent in plasma cell leukemias. | 2005 Apr 20 |
2 |
| 15 |
15093752 | The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib. | 2004 May 1 |
6 |
| 16 |
14627979 | Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma. | 2003 Nov 20 |
1 |